Mer­ck CEO in­di­cates in­ter­est in GLP-1 com­bi­na­tion ther­a­pies, may pur­sue deals

Not want­i­ng to be left out in the cold, Mer­ck now plans to pur­sue GLP-1 com­bi­na­tion ther­a­pies amid grow­ing ex­cite­ment about the lu­cra­tive po­ten­tial of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.